(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $289.7 | $263.7 | $239.63 | |
Short term investments | ||||
Net receivables | $126 | $123.8 | $127.66 | |
Inventory | ||||
Total current assets | $447.2 | $422.4 | $406.96 | |
Long term investments | ||||
Property, plant & equipment | $44 | $38.3 | $37.93 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $1393.2 | $1383.1 | $1397.94 | |
Current liabilities | ||||
Accounts payable | $180.8 | $181.2 | $205.11 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $287.6 | $285.1 | $311.28 | |
Long term debt | $19.8 | $14.4 | $14.51 | |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $602.5 | $612.3 | $636.13 | |
Shareholders' equity | ||||
Retained earnings | $167.8 | $150.2 | $138.65 | |
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $243.76 | $742.77 | $385.54 | |
Short term investments | ||||
Net receivables | $115.53 | $76.11 | $49.25 | |
Inventory | ||||
Total current assets | $402.19 | $850.04 | $449.81 | |
Long term investments | ||||
Property, plant & equipment | $37.89 | $35.92 | $33.98 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $1389.06 | $1771.12 | $957.02 | |
Current liabilities | ||||
Accounts payable | $204.99 | $150.01 | $131.47 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $309.49 | $253.24 | $199.75 | |
Long term debt | $15.48 | $429.26 | $430.64 | |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $637.47 | $1032.3 | $789.74 | |
Shareholders' equity | ||||
Retained earnings | $136.78 | $105.47 | $68.89 | |
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | ||||
Interest expense | ||||
Net income | ||||
Net income | ||||
Income (for common shares) |
(in millions $) | 31 Jan 2022 | 30 Jan 2021 | 31 Jan 2020 | |
---|---|---|---|---|
Revenue | ||||
Total revenue | $561.2 | $380.4 | ||
Cost of revenue | ||||
Gross Profit | $441.78 | $319.01 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $388.12 | $270.12 | ||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $11.04 | -$21.91 | ||
Interest expense | -$13.03 | -$3.33 | ||
Net income | ||||
Net income | $12.57 | $11.73 | ||
Income (for common shares) |
(in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$206.87 | -$119.8 | -$47.26 | -$333.77 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$234.89 | -$32.37 | -$30.23 | $539.77 |
Effect of exchange rate | $63.23 | $40.53 | $8.51 | $19.01 |
Change in cash and equivalents | -$230.28 | -$27.21 | -$27.25 | $357.23 |
(in millions $) | 31 Jan 2022 | 30 Jan 2021 | 31 Jan 2020 | |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$333.77 | -$114.3 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $539.77 | -$4.69 | ||
Effect of exchange rate | $19.01 | $0.03 | ||
Change in cash and equivalents | $357.23 | $27.01 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |